PREVIEW

Growing Number of Americans Are Trying Weight-Loss Drugs. According to a recent poll, six percent of adults in the United States have already tried Ozempic or other brand name weight loss medications. 'Newsweek' reports that the Gallup poll numbers suggest that approximately 15.5 million Americans have used or are using an injectable diabetes medication. According to the poll, three percent of those users are specifically using the drug for weight loss. The poll found that people between the ages of 40 and 64 are the most likely to try Ozempic or competitors, like Wegovy or Saxenda. In 2017, the U.S. Food and Drug Administration (FDA) approved Ozempic to treat cardiovascular disease and diabetes. 'Newsweek' reports that while Ozempic has not been approved for weight-loss purposes, its competitor Wegovy was approved in 2021. Both drugs rely upon the active ingredient semaglutide, however, Wegovy contains a higher amount than Ozempic. The popularity of the drug has resulted in various makers reporting shortages. "The drug companies didn't anticipate how popular these drugs would become." Since they are being used for many issues, like diabetes, heart failure, obesity, this exacerbates the shortages significantly, Sue Decotiis, Triple-board-certified medical weight-loss doctor in New York City, via ‘Newsweek’. THIS VIDEO MUST NOT BE EDITED FOR LENGTH TO COMBINE WITH OTHER CONTENT